← Back to Clinical Trials
Recruiting NCT07158658

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure Ulcers

Trial Parameters

Condition Pressure Injury
Sponsor NuScience Medical Biologics, LLC
Study Type INTERVENTIONAL
Phase N/A
Enrollment 10
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-12-01
Completion 2026-03-01
Interventions
NeoThelium FT (HCT/P 361)

Brief Summary

This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Chronic Pressure Ulcers

Eligibility Criteria

Inclusion Criteria: 1. Male or Female, 18 years of age or older 2. Subject has a medical diagnosis of Pressure Injury/Ulcer located on the pelvis or lower extremity 3. Subject has a Pressure Injury/Ulcer Stage 2 or 3 without infection 4. Index ulcer is a minimum of 1cm2 and a maximum of 30cm2 at first treatment visit 5. Index ulcer has a depth of ≤ 1cm2, and subject is compliant to use continuous NPWT with 75-100mmHg, at the providers discretion 6. Index ulcer has a depth of \> 1cm2, and subject is compliant to use continuous NPWT with 75-100mmHg 7. Pressure Injury/Ulcer is treated with offloading therapy while standing, sitting and lying down (if applicable to wound location) for 7 days prior to the first treatment visit 8. Adequate circulation of ulcer, if located on the lower extremity, demonstrated by an ABI of \>0.7 and \<1.3, or TBI of \>0.6 within 30 days prior to the first treatment visit 9. Index ulcer is free of infection prior to the first treatment visit and during screenin

Related Trials